Clinical Trials Directory

Trials / Completed

CompletedNCT02510651

Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo

Effect of Procedural-Related Variables on Melanocyte-Keratinocyte Suspension Transplantation in Non-Segmental Stable Vitiligo: A Clinical and Immunohistochemical Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

ORSHFS grafts yielded lower cell counts than NCECS but the M-K ratio and resultant repigmentation did not show significant difference with better healing of the donor site. Compared to cryoblebs, CO2 gave more homogenous pigmentation. The acral sites showed better results using combination of donor NCECS and recipient cryoblebs.

Detailed description

Background: Melanocyte-keratinocyte suspension (M-K susp) is gaining popularity for vitiligo treatment. Few studies have addressed procedure-related variables. Objective: To assess the effect of different M-K susp procedure-related variables on the clinical outcome in stable vitiligo. Methods: This retrospective study included 40 cases with stable non-segmental vitiligo treated by M-K susp followed by narrow band- ultraviolet B phototherapy twice weekly. Donor site was either a skin graft in non-cultured epidermal cell suspension (NCECS) (34 cases) or hair follicle unit in Outer Root Sheath Hair Follicle Suspension (ORSHFS) (6 cases). Recipient site was prepared by either cryoblebbing (24 cases) or carbon dioxide (CO2)laser resurfacing (16 cases). Cell counts and viability were recorded in the cell suspensions, and tissue melanocytes and keratinocytes were examined by Melan A and Cytokeratin respectively. Assessment of repigmentation was done 18 months after the procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREMelanocyte-keratinocyte suspensionTreatment of non-segmental vitiligo by CO2 laser followed by melanocyte-keratinocyte suspension.

Timeline

Start date
2010-01-01
Primary completion
2014-01-01
Completion
2014-06-01
First posted
2015-07-29
Last updated
2015-07-29

Source: ClinicalTrials.gov record NCT02510651. Inclusion in this directory is not an endorsement.